Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.

We undertook a prospective, randomized, non-blinded pilot study to determine whether infants with respiratory distress syndrome (RDS) who were treated with protein-containing bovine surfactant (Survanta, Ross/Abbott Laboratories, Columbus, Ohio) had earlier and larger responses in gas exchange when...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sehgal, S. S., Ewing, C. K., Richards, T., Taeusch, H. W.
Format: Artigo
Jezik:Inglês
Izdano: National Medical Association 1994
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2607653/
https://ncbi.nlm.nih.gov/pubmed/8151722
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items